The British Business Bank has committed £180 million to six venture and growth funds focused on AI and deep technology. Announced on 15 October, the investments spread public capital across managers backing companies at different stages of development.[1]
A fund investment puts capital behind a manager’s investment strategy. That manager selects a portfolio of companies and works with them as they grow. The Bank’s own Patient Capital Funds programme describes its role as making a cornerstone commitment that lets a fund begin investing, or helping it reach a more effective size.[2]
The six Bank commitments
| Fund | Bank commitment | Investment stage |
|---|---|---|
| Crane III | £35m | Inception to seedSource 1 |
| Connect V | £20m | Pre-seedSource 1 |
| Entrepreneurs First Early Stage | £22m | Seed, Series A and BSource 1 |
| Intrepid Growth Partners I | £55m | GrowthSource 1 |
| Headline EU VIII | £26m | Seed and Series ASource 1 |
| Evantic I | £22m | GrowthSource 1 |
Capital follows a manager’s decisions
The programme invests on commercial terms, seeking returns while managing risk. It assesses fund-management teams and their track records, including emerging managers’ ability to build lasting investment businesses. Public money therefore remains exposed to investment outcomes, while the company-selection work sits with specialists.[2]
Crane offers a concrete example of what that relationship is intended to provide. In September it described support for finding customers, recruiting, preparing subsequent financing and entering new markets. Those are useful capabilities for a young technical business to seek alongside cash; the manager’s ability to deliver them becomes part of the investment proposition.[3]
Crane III itself was announced at US$169 million within a four-fund platform totalling US$484 million. The £35 million British Business Bank commitment belongs to that specific fund: one investor’s contribution inside a larger capital pool.[3][1]
A route from first investment to expansion
The six backed funds collectively raised more than £1 billion, according to the Bank. Fundraising brings capital into those vehicles; investments in individual companies put it to work.[1]
Patient Capital Funds concentrates on venture growth, while using earlier-stage investments to help build a pipeline of companies for later rounds. It can also invest directly alongside managers in businesses already within its underlying portfolio. Those are two ways to follow a promising company as its financing needs change.[2]
The Bank’s most consequential choice is therefore a level above the startup: which investors it trusts to supply both capital and judgement as a company develops.[2]
Sources & further reading
- British Business Bank commits £180m across six AI and deeptech VC funds British Business Bank · 15 Oct 2026 · Accessed 18 Oct 2026
- Patient Capital Funds British Business Bank · Accessed 18 Oct 2026
- Big Week for Crane. Even Bigger for Founders. Crane Venture Partners · 21 Sep 2026 · Accessed 18 Oct 2026